Displaying 69 UK Pharma companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Pheon Therapeutics HIRING

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

79
$120M · Series B TCG Crossover, Atlas Ventures, Brandon Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@pheontx.com
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Apollo Therapeutics

Portfolio of pharmaceutical research and discovery.

64
$33M · Series C Patient Square Capital, Rock Springs Capital, M&G Investments 1 to 10 Biotech, Pharma London, UK •••••••••••@apollotherapeutics.com
ReViral

Biotechnology firm developing antiviral treatments for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
Flarin

Patent-protected anti-inflammatory painkiller.

54
$6M · Series A ITV AdVentures 1 to 10 Biotech, Pharma B2C London, UK •••••••••••@flarin.co.uk
Manual

Platform offering diagnostic tools and testing to aid patients in making health-related decisions.

50
$6M · Seed Felix Capital, Cherry Ventures, FJ Labs 11 to 50 Health Tech, Fashion, Pharma, Mobile, Ecommerce B2C London, UK •••••••••••@manual.co
Myricx Pharma

Drug discovery platform focused on developing small molecule inhibitors.

50
$6M · Seed Sofinnova Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@myricxpharma.com
Pear Bio

Cancer treatment predictor software.

50
$14M · Series A Hoxton Ventures, Octopus Ventures, Fly Ventures 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@pearbio.com
Lyphe group

Supplier of medical cannabis care and medicine.

50
$6M · Series A Leafy Tunnel 51 to 100 Health Tech, Agritech, Pharma, Manufacturing, Cannabis B2B London, UK •••••••••••@LYPHEGROUP.com
Epsilogen

Immuno-oncology company treats cancer with antibodies.

43
$2M · Series A AlbionVC, Novartis Venture Fund, Epidarex Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics B2B London, UK •••••••••••@epsilogen.com
NK:IO

Immunotherapy for the treatment of cancer.

43
$1M · Seed Cancer Research Horizons, UK Innovation & Science Seed Fund 11 to 50 Biotech, Pharma B2C London, UK •••••••••••@nk-io.com
Charac

App that streamlines access to your local pharmacy, helping you skip the queue and manage prescriptions from anywhere.

43
$1M · Seed NPA, MedAdvisor 1 to 10 Pharma, Mobile, Ecommerce B2C, Marketplace London, UK •••••••••••@charac.co.uk
Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

43
$2M Hoxton Ventures, Bessemer Venture Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B London, UK •••••••••••@peptone.io
Beckley Psytech

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

42
$40M · Series B Leafy Tunnel, ATAI Life Sciences 1 to 10 Biotech, Pharma B2C Oxford, UK •••••••••••@beckleypsytech.com
Exogene

Biotechnology platform accelerating cancer cell therapy discoveries with AI-driven TCR-antigen screening.

39
$104k · Pre Seed Atomico, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics B2B London, UK •••••••••••@exogene.co.uk
Tuli Health

Digital health platform providing instant access to private medical appointments and testing.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, CPG & Consumer Goods, Pharma B2B, SaaS London, UK •••••••••••@tuli.health
Phlo HIRING

Digital pharmacy platform.

39
$180k · Seed Scottish Investment Bank, Par Equity 51 to 100 Pharma B2C, SaaS London, UK •••••••••••@wearephlo.com
Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

39
$1M · Seed Mankind Pharma 1 to 10 Biotech, Pharma London, UK •••••••••••@actimedtherapeutics.com
Healx

Platform for discovering new drugs for rare diseases using AI technology.

37
$56M · Series B Balderton Capital, Atomico, btov Partners 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Osler Diagnostics

Lab-quality diagnostics for anyone, anywhere, at any time.

37
$85M Oxford Science Enterprises 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Oxford, UK •••••••••••@oslerdiagnostics.com
F2G

Platform discovering and developing new drugs to treat severe fungal diseases.

37
$70M Sofinnova Partners, Novo A/S, Forbion Capital Partners 251 to 500 Health Tech, Biotech, Pharma, Genetics B2B Manchester, UK •••••••••••@f2g.com
Oxford Nanopore Technologies

Platform for analyzing single molecules like DNA, RNA, and proteins using nanopore-based electronic systems.

37
$275M Wellington Management 251 to 500 Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics B2B Oxford, UK •••••••••••@nanoporetech.com
MiNA Therapeutics

Biotechnology company focused on developing therapeutic medicines by harnessing gene activation mechanisms.

34
$29M 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Genetics B2B London, UK •••••••••••@minatx.com
Pangaea Data

Software solution that uses machine learning to make scientific and clinical data more meaningful.

34
N/A Ascension Ventures, Hambro Perks Ltd., IQ Capital Partners 1 to 10 Health Tech, AI, Machine Learning, Pharma, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@pangaeadata.ai
Synthace

Platform for automating life sciences experiments and integrating the resulting data.

34
N/A Sofinnova Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things B2B, SaaS London, UK •••••••••••@synthace.com
Veratrak

Supply chain platfrom for pharma.

31
$6M · Series A 11 to 50 Biotech, Pharma, Supply Chain & Logistics London, UK •••••••••••@veratrak.com
Nucleome Therapeutics

Platform focused on decoding the dark matter of the human genome to discover new treatments for diseases.

31
$43M Oxford Science Enterprises 1 to 10 Health Tech, Biotech, Pharma, Manufacturing, Genetics B2B Oxford, UK •••••••••••@nucleome.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
Re-Vana Therapeutics

Ocular pharmaceuticals and drug delivery solutions company.

26
$11M Techstart Ventures 1 to 10 Health Tech, Pharma, Business Intelligence Belfast, UK •••••••••••@revanatx.com
Axol Bioscience

Live human cell cultures and genome editing services for researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
PetMedix

Pet therapeutics startup dedicated to developing medicines for pets.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
PillSorted

Pharmacy service that combines caring customer support with modern technology for a personalized experience.

26
$6M · Seed Hoxton Ventures 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Ecommerce B2B, B2C, SaaS Cambridge, UK •••••••••••@pillsorted.com
Epitopea

Cancer immunotherapeutics company working across the Atlantic.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
CV6 Therapeutics

Drug development company focused on discovering, developing, and commercializing novel therapies.

26
$5M Techstart Ventures 1 to 10 Health Tech, Biotech, Pharma B2B Belfast, UK •••••••••••@cv6t.com
medino

Marketplace offering convenient online access to Health and Wellness products.

25
$574k · Seed 1 to 10 Health Tech, CPG & Consumer Goods, Pharma, Fitness, Mobile, Ecommerce B2C London, UK •••••••••••@medino.com
Clerkenwell Health

A psychedelic-specialist clinical research organisation.

25
$970k · Pre Seed 1 to 10 Health Tech, Biotech, Pharma, Business Intelligence B2B, SaaS London, UK •••••••••••@clerkenwellhealth.com
CONNECT Care

On a mission to power the pharmacy of the future, giving people the confidence to make the most of their medicines.

25
$344k · Pre Seed 1 to 10 Health Tech, Hardware, Pharma, Mobile, Media and Entertainement, Ecommerce, ElderTech B2C London, UK •••••••••••@weconnect.care
Pharmacierge

The free e-prescribing service chosen by Private GPs and Consultants to deliver medication to their patients nationwide

25
$1M · Seed 11 to 50 Health Tech, Pharma, Ecommerce B2B, B2C, Marketplace London, UK •••••••••••@pharmacierge.com
Immunocore

Biotechnology company develops TCR bispecific immunotherapies.

23
$75M · Series C 251 to 500 Health Tech, Biotech, Pharma B2B Abingdon, UK •••••••••••@immunocore.com
Oxford Drug Design

Platform specializing in computer-aided drug discovery and technology services.

21
$2M ACF Investors 1 to 10 Health Tech, Biotech, Pharma, Food Delivery, Manufacturing B2B, SaaS Oxford, UK •••••••••••@oxforddrugdesign.com
Flarin

Patent-protected anti-inflammatory painkiller.

18
N/A 1 to 10 Biotech, Pharma London, UK •••••••••••@
Ochre Bio

Biotechnology platform focused on rejuvenating transplant livers.

17
$150k · Pre Seed Hoxton Ventures, Khosla Ventures, BACKED VC 11 to 50 Health Tech, Biotech, Pharma B2B Oxford, UK •••••••••••@ochre-bio.com
Solvotrin Therapeutics

Pharmaceutical company improving and enhancing existing medications.

17
$7M 11 to 50 Health Tech, Biotech, Pharma B2B Cork, UK •••••••••••@solvotrin.com
Accession Therapeutics

Biopharma

17
$19M 11 to 50 Biotech, Pharma Oxford, UK •••••••••••@accessiontherapeutics.com
CardiaTec Biosciences

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

17
$1M · Pre Seed LinkedIn 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@cardiatec.ai
BrainWaveBank

Platform to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.

17
$1M · Seed Techstart Ventures 11 to 50 Health Tech, Hardware, Biotech, Deep Tech, Pharma B2B, SaaS Belfast, UK •••••••••••@brainwavebank.com
NRG Therapeutics

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

17
$18M 1 to 10 Health Tech, Biotech, Pharma B2B Cambridge, UK •••••••••••@nrgtherapeutics.com
Monocl

Platform for life science professionals to connect with global experts for strategic engagement.

14
$3M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@monocl.com
PharmEnable

Platform identifying chemical starting points to speed up drug discovery at lower costs.

14
$2M · Seed 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@pharmenable.com
e-therapeuticsJUST ADDED HIRING

Computational drug discovery platform.

1
$37M · Series B M&G Investments 11 to 50 Biotech, Pharma London, UK •••••••••••@etherapeutics.co.uk